The German Competence Network on Atrial Fibrillation (AFNET)

Herz

Volumn 33, Issue 8, 2008, Pages 548-555

  Breithardt, Günter ^a   Dobrev, Dobromir ^a,b   Doll, Nicolas ^a,c   Goette, Andreas ^a,d   Hoffmann, Boris ^a,e   Kirchhof, Paulus ^a   Köster, Ilka ^a,f   Kuck, Karl Heinz ^a,f   Leute, Angelika ^a   Meinertz, Thomas ^a,e   Näbauer, Michael ^a,g   Oeff, Michael ^a,h   Ravens, Ursula ^a,b   Schuchert, Andreas ^a,i   Sprenger, Claudia ^a,h   Steinbeck, Gerhard ^a,g   Willems, Stephan ^a,e  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c SANA KLINIKUM OFFENBACH   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY HEART CENTER HAMBURG   (Germany)

^f DEPARTMENT OF CARDIOLOGY   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h Municipal Hospital   (Germany)

ⁱ Friedrich Ebert Krankenhaus   (Germany)

Author keywords

Ablation; Antiarrhythmic drugs; Atrial fibrillation (AF); Atrial remodeling; Cardioversion; Preventive pacing; Pulmonary vein isolation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE; OLMESARTAN; PLACEBO; VASCULAR CELL ADHESION MOLECULE 1;

AGING; ANTICOAGULATION; ARTICLE; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEVICE THERAPY; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG EFFICACY; ELECTROCARDIOGRAPHY MONITORING; GERMANY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART CONTRACTION; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MEDICAL RESEARCH; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PATIENT COMPLIANCE; PROTEIN EXPRESSION; PULMONARY VEIN; QT PROLONGATION; RECURRENT DISEASE; REGISTER; RISK REDUCTION; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

EID: 58449102677     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-008-3177-2     Document Type: Article

References (25)

1. E. Bertaglia F. Zoppo C. Tondo 2007 Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety Heart Rhythm 4 1265 1271
2. R. Cappato H. Calkins S.A. Chen 2005 A worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circulation 111 1100 1105
3. S.A. Chen M.H. Hsieh C.T. Tai 1999 Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation Circulation 100 1879 1886
4. KACh is constitutively active in patients with chronic atrial fibrillation Circulation 112 3697 3706
5. Doll N, Mohr FW. Herzchirurgische Therapiever fahren bei Vorhofflimmern. In: Neuzner J, Pitschner H, Hrsg. Vorhofflimmern, Vorhofflattern. Aktuelle Diagnostik und Therapie, 2. Aufl. Darmstadt: Steinkopff, 2006:317-333.
6. 2+-handling in human chronic atrial fibrillation Circulation 114 670 680
7. T. Fetsch P. Bauer R. Engberding 2004 Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial Eur Heart J 25 1385 1394
8. V. Fuster L.E. Ryden R.W. Asinger 2001 ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation Eur Heart J 22 1852 1923
9. V. Fuster L.E. Ryden D.S. Cannom 2006 ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary Eur Heart J 27 1979 2030
10. A.S. Go E.M. Hylek K.A. Phillips 2001 Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2370 2375
11. A. Goette G. Breithardt T. Fetsch 2007 Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) trial: rationale and study design Clin Drug Invest 27 697 705
12. A. Goette A. Bukowska U. Lendeckel 2008 Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression Circulation 117 732 742
13. S. Kääb U. Schotten D. Dobrev 2007 Grundlagenfor schungist eine Voraussetzung für innovative pharmakologische Therapieansätze bei Vorhofflimmern Med Welt 58 131 134
14. P. Kirchhof A. Auricchio J. Bax 2007 Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace 9 1006 1023
15. P. Kirchhof A. Auricchio J. Bax 2007 Outcome parameters for trials in atrial fibrillation: executive summary Eur Heart J 28 2803 2817
16. P. Kirchhof L. Eckardt M.R. Franz 2003 Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome J Cardiovasc Electrophysiol 14 1027 1033
17. P. Kirchhof T. Fetsch P. Hanrath 2005 Targeted pharmacological reversal of electrical remodeling after cardioversion-rationale and design of the Flecainide Short-Long(Flec-SL) trial Am Heart J 150 899
18. R.L. McNamara 2004 ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation J Am Coll Cardiol 44 475 495
19. R. Nieuwlaat A. Capucci A.J. Camm 2005 Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation Eur Heart J 26 2422 2434
20. F. Oyang M. Antz S. Ernst 2005 Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique Circulation 111 127 135
21. C. Pappone S. Rosanio G. Oreto 2000 Circumferential radio-frequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation Circulation 102 1271 1282
22. T.J. Wang J.M. Massaro D. Levy 2003 A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study JAMA 290 1049 1056
23. W.A. Wattigney G.A. Mensah J.B. Croft 2002 Increased atrial fibrillation mortality: United States, 1980-1998 Am J Epidemiol 155 819 826
24. P.A. Wolf R.D. Abbott W.B. Kannel 1991 Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 983 988
25. Zellerhoff S, Pistulli R, Moennig G, et al. Atrial arrhythmias in long QT syndrome - a nested case control study. J Cardiovasc Electrophysiol 2008:in press.